SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors upcoming FDA decision on deramiocel for Duchenne muscular dystrophy is driving attention, with traders focused on the November 22 target date, amended upper-limb data and recent commercial-launch job postings. Many expect approval and anticipate short covering, while others stress that hiring and FDA rare-disease messaging are not proof of a favorable decision and point to the prior setbacks and remaining efficacy questions.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A run to a 52-week high has traders positioning around the expected Q3 earnings report, with BRIUMVIs sales growth supporting optimism. Buyout rumors and heavy short interest are fueling squeeze speculation, though some traders see earnings expectationsnot a confirmed acquisitionas the main driver.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios reported FDA approval of a competing RRP treatment has fueled debate over the threat to Precigens PAPZIMEOS and whether the selloff is an overreaction; traders disagree on the therapies relative advantages and Precigens commercial head start. Attention is also turning to upcoming PRGN-2009 clinical data and a Q3 business update.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is under pressure after a steep decline, with traders focused on analyst price-target cuts and uncertainty ahead of its earnings report, as well as concerns about digital-ad growth. Bulls argue the selloff is disconnected from the companys profitability and growth, while bears warn of more downside if results or guidance disappoint; some also point to broader tech-market weakness.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs Phase 3 REGAL leukemia trial reached its prespecified 80th death event, triggering final analysis and putting the GPS survival readout at the center of discussion. Traders are divided between optimism about a strong result and concerns about the control arm and trial design, while shares have come under pressure ahead of the binary catalyst.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that Medicares post-TDAPA reimbursement contribution for DefenCath could decline through 2027 is driving the sharp selloff and debate over future revenue. Some traders view the comments as a serious pricing risk, while others argue DaVitas estimates are preliminary and point to CMSs more favorable payment assumptions; several describe the decline as an overreaction.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

SMH is under pressure amid a semiconductor and tech selloff, as traders question whether heavy AI infrastructure spending will generate adequate returns; weak Intel guidance and concerns about Amazons elevated capex are cited as contributing pressures. The community is divided between expecting a deeper unwind in the AI trade and seeing oversold conditions and technical support as possible grounds for a bounce.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A sharp Nasdaq selloff has put QQQ in correction territory, with traders linking the pressure to weakness across technology and AI-related stocks, worries about returns on heavy AI spending, and rising-rate concerns. The community is split between bears expecting further losses and dip-buyers anticipating a relief bounce or short squeeze.

Okta, Inc. engages in the provision of an identity management platform for enterprises. The firm operates through the following geographical segments: United States and International. Its products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Oktas strong quarterly results and raised outlook, alongside expectations that AI agents will increase demand for identity security, fueled a sharp rally. Traders are now debating whether the growth outlook justifies the valuation, with some taking profits or positioning for a pullback.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Lines stronger-than-expected third-quarter results and raised full-year outlook sparked a sharp rally, with traders debating whether heavy short interest could amplify the move. The reaction is mixed: some see evidence of a turnaround, while others point to profit-taking, fuel-cost pressures and lingering concerns about bookings and yields.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

OKTA vs. S: Which Enterprise Cybersecurity Stock Has an Edge Now?

Okta has an edge over SentinelOne, with stronger profitability, robust cash flow and expanding AI-agent security capabilities despite slower revenue growth.

SentinelOne Named Pax8s Partners Most Valuable Vendor in EMEA at Beyond EMEA 2026

SentinelOne (NYSE: S), the AI Security leader, today announced it has received a Pax8 Beyond Partners Most Valuable Vendor Award in EMEA during Pax8s Beyond EMEA 2026 conference. The awards program recognizes vendors that have a significant impact on the channel ecosystem through strategic...

SentinelOne to Add Anthropics Claude Mythos 5.1 to Wayfinder Frontier AI Services

SentinelOne (NYSE: S), the AI Security leader, today announced the upcoming addition of Anthropic Claude Mythos 5.1 to its Wayfinder Frontier AI Services offering. Designed to help customers proactively secure their code and digital operations from AI-scaled threats, Wayfinder Frontier AI Services...

Can PANW Turn Frontier AI Defense Into a Key Growth Driver?

Palo Alto Networks expands AI-driven cybersecurity with Continuous Frontier AI Defense, offering recurring revenue potential as AI threats rise.

CrowdStrike vs. SentinelOne: Which Cybersecurity Stock Is a Better Buy in 2026?

Key PointsCrowdStrike dominates the market with its unified Falcon platform and expanded AI-native strategic partnerships...

SentinelOne (S) Stock Moves -1.19%: What You Should Know

In the closing of the recent trading day, SentinelOne (S) stood at $22.5, denoting a -1.19% move from the preceding trading day.

Tesla To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Thursday

Analysts raised targets for Tesla, Thermo Fisher, SentinelOne, Meta and Philip Morris; cut targets for Pegasystems, AT&T and Oklo.read more...

As AI Accelerates Cyberattacks, N-able and SentinelOne Expand Their Strategic Partnership to Advance Resilience

N-able, Inc. (NYSE: NABL), a global cybersecurity company delivering end-to-end business resilience, and SentinelOne (NYSE: S), the AI Security leader, today announced an expansion of their longstanding partnership at OneCon 2026, SentinelOne's annual customer conference. Building on years of...

SentinelOne and Lenovo Expand Partnership to Bring AI Security & Governance to the ThinkShield Security Portfolio

SentinelOne (NYSE:S), the AI Security leader, today announced an expanded partnership with Lenovo that will bring SentinelOnes AI security to Lenovos ThinkShield security portfolio. The expansion builds on Lenovo's existing collaboration with SentinelOne for endpoint detection and response (EDR...

SentinelOne Names LevelBlue Global Delivery Partner for Wayfinder Services

SentinelOne (NYSE: S), the AI Security leader, today announced that it has named LevelBlue, the world's largest pure-play managed security services provider (MSSP), as its global exclusive delivery partner for Wayfinder services, SentinelOne's suite of AI-powered managed security and threat...

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

Why Did OKTA, S, META Stocks Jump To 52-Week Highs Today?

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>OKTA shares closed up 0.62% after receiving a series of price target hikes from Wall Street analysts amid growing optimism over autonomous AI agents.&nbsp;</li><li>S stock climbed higher during the regular trading session on the announcement that it was expanding Wayfinder Threat Hunting to public cloud services but closed 0.48% down.&nbsp;</li><li>META stock jumped 4.5% at close amid growing interest in its Muse AI launch, even as analysts raised the price target.&nbsp;</li></ul><p>Shares of Okta Inc. (OKTA), SentinelOne Inc. (S) and Meta Platforms Inc. (META) jumped to 52-week highs on Thursday amid a series of positive catalysts and Wall Street optimism.&nbsp;</p><p><a href="https://stocktwits.com/symbol/OKTA">OKTA shares</a> closed up 0.62% after receiving a series of price target hikes from Wall Street analysts amid growing optimism over autonomous AI agents.&nbsp;</p><p><a href="https://stocktwits.com/symbol/S">S stock</a> climbed higher during the regular trading session on the announcement that it was expanding Wayfinder Threat Hunting to public cloud services but closed 0.48% down.&nbsp;</p><p><a href="https://stocktwits.com/symbol/META">META stock</a> jumped 4.5% at close amid growing interest in its Muse AI launch, even as analysts raised the price target.&nbsp;</p><h2 class="st-heading-2">OKTA Gains From Wall Street Optimism Over Autonomous AI</h2><p>OKTA stock notched a fresh 52-week high of $212.50 on Thursday, extending to four consecutive days in the green, as multiple Wall Street analysts raised the price target.&nbsp;</p><p>According to The Fly, Evercore ISI raised Okta's price target to $240 from $185 and maintained an ‘Outperform’ rating, implying upside of more than 16% from its last close. The analyst said that the hike followed a briefing from the company at Oktane26, where Okta indicated that agentic identity momentum continues to build. The analyst said the firm’s "reacceleration narrative" remains intact.</p><p>Truist raised the price target on Okta to $235 from $200 and kept a ‘Buy’ rating on the shares after attending Okta's Oktane26 conference. The analyst said it left with greater clarity on the company's long-term AI strategy and was encouraged by Okta's focus on open standards, ecosystem partnerships, and lowering barriers to agent adoption.</p><div><figure class="table"><table class="ck-table-resized"><colgroup><col><col><col></colgroup><tbody><tr><td><strong>Analyst</strong></td><td><strong>New Price Target</strong></td><td><strong>Upside / Downside From Last Close</strong></td></tr><tr><td>Citi</td><td>$205</td><td>-0.79%</td></tr><tr><td>KeyBanc</td><td>$240</td><td>16.12%</td></tr><tr><td>Truist</td><td>$235</td><td>13.72%</td></tr><tr><td>Roth Capital</td><td>$235</td><td>13.72%</td></tr><tr><td>TD Cowen</td><td>$200</td><td>-3.21%</td></tr><tr><td>DA Davidson</td><td>$235</td><td>13.72%</td></tr><tr><td>RBC Capital</td><td>$230</td><td>11.31%</td></tr><tr><td>Evercore ISI</td><td>$240</td><td>16.12%</td></tr><tr><td>Oppenheimer</td><td>$227</td><td>9.85%</td></tr><tr><td>Mizuho</td><td>$200</td><td>-3.21%</td></tr><tr><td>Stifel</td><td>$215</td><td>4.05%</td></tr><tr><td>Guggenheim</td><td>$227</td><td>9.85%</td></tr><tr><td>Wells Fargo</td><td>$230</td><td>11.31%</td></tr><tr><td>BofA</td><td>$220</td><td>6.46%</td></tr><tr><td>Barclays</td><td>$215</td><td>4.05%</td></tr><tr><td>Jefferies</td><td>$240</td><td>16.12%</td></tr></tbody></table></figure></div><p>On Stocktwits, retail sentiment around OKTA dropped from ‘bullish’ to ‘neutral’ over 24 hours. Shares of the company have gained about 147% so far in 2026.&nbsp;</p><h2 class="st-heading-2">SentinelOne Expands Wayfinder Threat Hunting To Public Cloud Services</h2><p>S stock climbed to a fresh 52-week high of $24.40 on Thursday, although the shares were lower at close. The stock is on track to clock a second consecutive week in green.&nbsp;</p><p>On Thursday, SentinelOne announced the expansion of Wayfinder Threat Hunting to the major public cloud services including AWS, Azure, and Google Cloud. The latest offering combines its AI-powered Singularity Platform telemetry with expert human-led hunting to protect against attacks across AI, endpoints, identities, and cloud workloads.&nbsp;</p><p>The firm said that its Wayfinder Threat Hunting continues to expand its protection, first across the endpoint, then into identity with hunting for Okta and Microsoft Entra ID, and now into the cloud control plane itself.&nbsp;</p><p>On Stocktwits, retail sentiment around S was ‘neutral’ at the time of writing. Shares of the company have gained nearly 64% year-to-date.&nbsp;</p><h2 class="st-heading-2">Meta Gains From Optimism Around Product Launches Such As Muse AI, New VR Glasses</h2><p>META stock hit a 52-week high of $779.82 on Wednesday, putting it on track for a fifth consecutive week of gains.&nbsp;</p><p>At its Meta Connect 2026 event on Wednesday, the company debuted its Meta VR Glasses and the AI-powered Muse Charm, a pocket-sized, keychain-friendly standalone hardware device. Meta also launched a range of new Meta Ray-Ban VR Glasses.</p><p>Citizens raised the price target on Meta Platforms to $885 from $770 and kept an Outperform rating on the shares, implying an upside of nearly 14% from its last close. The analyst’s hike followed the Meta Connect event, which the firm said highlighted an increasingly AI-first hardware ecosystem and early Muse momentum, with the consumer-focused agent potentially expanding Meta's share of AI usage and eventually enabling new monetization opportunities.&nbsp;</p><p>JPMorgan analyst Doug Anmuth also hiked the price target on Meta to $920 from $820 and maintained an ‘Overweight’ rating on the shares following the conference.&nbsp;</p><p>The analyst said that Meta "continues to move towards superintelligence with Muse off to a strong start," and that it believes Muse has potential to bring an "extremely capable personal agent to billions of users." JPMorgan expects Muse adoption and engagement to continue to ramp.</p><p>On Stocktwits, retail sentiment around META stock was ‘bullish’ at the time of writing. The company's shares have climbed more than 19% so far this year.&nbsp;</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, a hand holds a smartphone displaying the logo of Okta Inc.

Okta, SentinelOne and Meta Platforms jumped to 52-week highs on Thursday amid a series of positive catalysts and rising Wall Street optimism.

SentinelOne Inc

$CRWD

$PANW

$NET

Cybersecurity is one of the market's most crowded trades right now, and $CRWD, $PANW, $NET, and $ZS each represent a different bet on where the next leg of growth comes from. If you had to put your money behind just one for the next 12 months, which are you choosing? Explain your reasoning in the comments.

Which cybersecurity stock will post the best performance over the next 12 months? 
 
Drop a comment for other tickers.

Current Price	$25.15
Prev Close	$25.71
Open	$25.47
Dividend Yield	0.00%
50-Day Moving Average	$22.84
Beta	1.49
Avg. Volume	8.92M
PE Ratio	-25.46

52-Week High	$26.50
52-Week Low	$11.81
Market Capitalization	$8.95B
EPS (Annual)	-$1.37
Price to Book	6.14
Revenue Per Employee	$345,268.28

Feed

News

Sentiment

Earnings

Fundamentals

Info

S Fundamentals